A detailed history of Aqr Capital Management LLC transactions in Merus N.V. stock. As of the latest transaction made, Aqr Capital Management LLC holds 13,549 shares of MRUS stock, worth $672,843. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,549
Previous 8,470 59.96%
Holding current value
$672,843
Previous $501,000 34.93%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$47.19 - $58.84 $239,678 - $298,848
5,079 Added 59.96%
13,549 $676,000
Q2 2024

Aug 14, 2024

SELL
$39.81 - $60.2 $13,216 - $19,986
-332 Reduced 3.77%
8,470 $501,000
Q1 2024

May 15, 2024

BUY
$28.03 - $51.82 $246,720 - $456,119
8,802 New
8,802 $396,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.28B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.